lecturer of biotechnology in university
He is a researcher. His area of expertise is Metabolic Syndrome, heart disease and diabetes. He has served as an peer-reviewed editor for several reputed journals and also published several research papers in the international journals.
Philip was awarded a PhD in 1997 for a thesis concerning automatic and effortful information processing in ADHD. His other research output spans youth suicide and deliberate self-harm, mood disorders, autism, children in out-of-home care, systematic review of treatment effectiveness, psychological sequelae of disaster, and the evaluation of medical education. He was in 2004 honoured by the American Academy of Child and Adolescent Psychiatry with the Elaine Schlosser Lewis Award for Research in Attention Deficit Disorder. He is currently a co-investigator on funded longitudinal studies of children with Attention Deficit Hyperactivity Disorder and of determinants of health and wellbeing in adolescents in rural New South Wales. He is also a co-investigator on a funded clinical trial of fluoxetine for autism.
Journal of Metabolic Syndrome received 48 citations as per Google Scholar report